| 摘要 |
FIELD: medicine, pharmaceuticals. ^ SUBSTANCE: described is compound or receptor including {Gal(A)q(Nac)r/Gal(A)q(Nac)ralpha3/beta3]s[Galbeta4GlcNAcbeta3]tGalbeta4Glc(Nac)u oligosaccharide sequence, binding of Helicobacter pylori wherein q, r, s, t, and u are independently 0 or 1, analogs or derivatives thereof as epitope binding to Helicobacter pylori and application thereof, in particular, in pharmaceutical and food composition for treatment conditions associated with presence of Helicobacter pylori. ^ EFFECT: increased treatment effectiveness. ^ 18 cl, 11 dwg |
